Silexion Therapeutics LTD (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
0.93
0.01 (0.92%)
At close: Jun 06, 2025, 3:59 PM
0.93
-0.10%
After-hours: Jun 06, 2025, 05:24 PM EDT
0.92% (1D)
| Bid | 0.9 |
| Market Cap | 8.09M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.34M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -0.48 |
| Forward PE | -0.88 |
| Analyst | Buy |
| Ask | 0.96 |
| Volume | 253,712 |
| Avg. Volume (20D) | 1,830,541 |
| Open | 0.93 |
| Previous Close | 0.92 |
| Day's Range | 0.92 - 0.96 |
| 52-Week Range | 0.21 - 13.56 |
| Beta | 0.12 |
About SLXN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLXN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLXN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+1.82%
SLXN stock has given up its prior gain. Sliexion T...
Unlock content with
Pro Subscription
2 weeks ago
+1.82%
Sliexion Therapeutics shares are trading higher after the company announced it completed its preclinical study assessing SIL204.
